Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BaiDiZiYin and ShenQiYiFei Pills in Newly Diagnosed Pulmonary Tuberculosis
NCT06403943Phase 4Recruiting
- Sponsor
- Beijing Chest Hospital
- Start
- May 2023
- Primary completion
- Oct 2026
- Modality
- HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Baidi Ziyin Pill in pulmonary tuberculosis (TB) (2 arms), sponsored by Beijing Chest Hospital. Primary endpoint: Improvement of symptoms at 2 months. Started May 2023; status: recruiting.
02
Drugs
Baidi Ziyin Pill
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT06403943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06403943.